Download Bucharest Forum / Healthcare 5th Edition A

yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Infection control wikipedia , lookup

Sabin Manuilă wikipedia , lookup

Bucharest Forum / Healthcare 5th Edition
A Healing Revolution: Patient and Community Centred Medicine
9 June, 2016
Cotroceni Palace, Theatre Hall
Working Agenda
08:30 – 09:30
09:30 – 09:45
Welcome address
Mircea Geoană, President, Aspen Institute Romania
09:45 – 10:00
Keynote Speech
Dacian Cioloș, Prime Minister of Romania (TBC)
10:00 – 10:15
Keynote Speech
Vlad Voiculescu, Minister of Health (TBC)
10:15 – 10:30
Opening remarks
Diana Loreta Păun, State Counselor, Public Health department, Romanian
Presidential Administration
10:30 – 11:30
The 21st century Medicine: the Role of Technology evolution and R&D
towards innovative personalized healthcare solutions
Scientific advancements outline a path towards ‘personalized medicine, a targeted approach to the
prevention, diagnosis and treatment of disease based on an individual’s specific genetic profile. In
fact, in recent years therapeutic alternatives based on the study of genetic profiles have been
developed, but use of genetic data to inform medical decisions is still lagging behind.
Nic Voiculescu, MD, EMBA, Managing Director, Link Resource Romania
Adrian Curaj, Minister of National Education and Scientific Research (TBC)
Dr. François Regis Martelet, Group CEO NetScientific plc, London
Markus Glimm, CEO TRx CARE
Hans Christian Hoeck, M.D., PhD, Chief Executive Officer, CCBR Clinical Research,
Bioclinica, Switzerland
Prof. Dr. Alexandru Irimie, Rector, Medicine and Pharmacy University “Iuliu Hațieganu”,
Cluj (TBC)
Ion Sturza, Founder and Chairman of Fribourg Capital, Member of AIR Board (TBC)
Dr. David Ribeiro, CEO, ProAksis (TBC)
11:30 – 11:45
Coffee break
Strada Italiană nr. 25, etajul 1, 020974, București, România | Tel.: +40 21 316 4279 | Fax: +40 21 317 3443
[email protected] |
11:45 – 13:30
Eradication of a Disease in 21st century Europe: Romania Hep C case study
The growing availability of highly effective treatments for genotype 1 infection is limited by the cost
of new agents. One dimension of the discussion is related to the selection of treatment regimens. In
the case of patients with genotype 1 infection, this should take into consideration efficacy, duration
and adverse effects, the profile of the regimen, potential drug interactions, prior patient history and
the stage of the illness. For individual patients, the financial component represents an important
dimension to be considered.
Andrei Țărnea, Executive Director, AIR
Diana Loreta Păun, State Counselor, Public Health department, Romanian Presidential
Corina Silvia Pop, Secretary of State, Ministry of Health (TBC)
Cristian Bușoi, Member of the European Parliament
Andrew Stainthorpe, Executive Director, PASLU, NICE
Prof. Dr. Adrian Streinu – Cercel, General Manager, Infectious Diseases Institute “Prof.
Dr. Matei Balş”
Gheorghe Radu Țibichi, President of the National Health Insurance House, Romania
Florentina Furtunescu, Head Unit, Public Health and Management, “Carol Davila
”University of Medicine and Pharmacy, Bucharest (TBC)
Nicolae Bănicioiu, Member of the Romanian Parliament (TBC)
Mihaela Geoană, President, “Renaşterea” Foundation (TBC)
Oana Cuzino, MD, Healthcare Media Expert, TV Producer, MediaPro Group (TBC)
13:30 – 14:30
14:30 – 16:00
Roundtable discussion
Healthcare Sector: Sustainability and Systemic Efficiency in the Pharma
Sector via HTA and Managed - Entry Arrangements
In Romania and the rest of Europe, healthcare budgets, both public and private, are coming under
increasing pressure due to demographical patterns and financial difficulties, while the medical needs
are growing and diversifying. This raises the problem of reforming the financing of the healthcare
sector in order to make it more sustainable and able to meet the challenges of an ageing population.
The goal is to achieve low costs and full consumer choice of providers and quality of care, for
instance by means of combining universal medical savings accounts with supplementary programs
to protect vulnerable patient categories.
Vlad Mixich, Editorial Director, / Medical Life (TBC)
 Anca Dragu, Minister of Public Finance
 Cristian Bușoi, Member of the European Parliament
 Thomas Allvin, Director Health Systems, European Federation of Pharmaceutical
Industries and Associations
Dr. François Meyer, Advisor to the President, International Affairs, Haute Authorité de
Dr. Nicolae Fotin, President, National Agency for Medicines and Medical Devices (TBC)
Mihai Purcărea, Manager BRD - Soc Gen, BRD Asset Management (TBC)
Pharma companies’ representatives (TBD)
Strada Italiană nr. 25, etajul 1, 020974, București, România | Tel.: +40 21 316 4279 | Fax: +40 21 317 3443
[email protected] |